Thank you for your interest in our activities! On the following pages you will find information about our aim, objectives, and current and past activities.
Due to the repeated importation of Measles to Columbia the country has implemented a new regulation demanding obligatory vaccination proof for international [more]
Eurartesim (Dihydroartemisinin/Piperaquin) a novel ACT has been licensed by the EMA (European Medicines Agency) in Nov. 2011. Eruartesim is licensed for the tre[more]
